PubMed Health⌕ Search

Biomedical subjects

L Haghighi

Publications and source records attributed to L Haghighi.

14 recordsLinked to original sources
PubMed1999

Prevention of preterm delivery: nifedipine or magnesium sulfate.

OBJECTIVE: to establish the efficacy and safety of nifedipine and magnesium sulfate in arresting preterm labor. METHOD: seventy-four patients with singleton pregnancies at 23-36 weeks in preterm labor, were selected randomly to receive either oral nifedipine or intravenous magnesium sulfate. RESULTS: both drugs had similar tocolytic efficacy and side effects while nifedipine was faster than magnesium sulfate in arresting uterine contractions (4.8 +/- 4.23 vs. 2.98 +/- 3.03 h) P = 0.04. CONCLUSION: this data suggests that oral nifedipine with the same efficacy, side effects and faster action could be a suitable and more convenient alternative to intravenous magnesium sulfate in arresting preterm labor.

Administration, Oral↗
PubMed1979

The first successful isolation and identification of Yersinia enterocolitica in Iran.

Since 1967, more than 2,000 specimens have been examined for the possible existence of Yersinia enterocolitica in Iran. Most of the specimens were stool and appendices. For primary isolation SS and EMB media were used and the cultures were incubated at 37 degrees C. In 1976 we isolated the first strain of Y. enterocolitica from the stool of a 10-month-old girl. She was suffering from chronic diarrhea. This strain was the first strain of Y. enterocolitica to be successfully isolated in Iran. It belongs to serotype 03,--biotype 4-phage type VIII. It has all the classical characteristics of Y. enterocolitica. However, in contrast to the strains found in northern Europe, it ferments d-xylose. Our finding was confirmed by internationally accepted Yersinia centers.

Anti-Bacterial Agents↗
PubMed1978

Isolation of Vibrio parahaemolyticus from Persian Gulf.

We have been able to establish, for the first time, the presence of V. parahaemolyticus in the waters of the Persian Gulf. Samples were collected from water, fish, shrimp, sand and sea vegetation around various coastal towns of the Persian Gulf during November 1977--April 1978. Various biochemical tests have confirmed the identification of an isolate from one of the water samples as V. parahaemolyticus.

Iran↗
PubMed1969

C-reactive protein in malaria.

C-Reactive protein has not been studied in malaria so far but with the reappearance of malaria in the southern part of Iran there is now an opportunity to study the behaviour of C-reactive protein in malaria. One hundred and sixty-two patients suffering from malaria have been so tested. Of those patients, 85.2% showed a positive result and among them more than 50% had a strongly positive reaction. It may be concluded that malaria is one of the outstanding diseases in which the C-reactive protein test is positive. Those patients who were examined for C-reactive protein in the first two days of the disease showed a negative result.

Adolescent↗